294 Appendices 170. Gaikwad A, Souza CA, Inacio JR, et al. Aerogenous metastases: a potential game changer in the diagnosis and management of primary lung adenocarcinoma. Am J Roentgenol. 2014;203(6):W570-W582. doi:10.2214/AJR.13.12088 171. Aly RG, Rekhtman N, Li X, et al. Spread Through Air Spaces (STAS) Is Prognostic in Atypical Carcinoid, Large Cell Neuroendocrine Carcinoma, and Small Cell Carcinoma of the Lung. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. 2019;14(9):1583-1593. doi:10.1016/j. jtho.2019.05.009 172. Walts AE, Marchevsky AM. Current Evidence Does Not Warrant Frozen Section Evaluation for the Presence of Tumor Spread Through Alveolar Spaces. Arch Pathol Lab Med. 2018;142(1):59-63. doi:10.5858/arpa.2016-0635-OA 173. Blaauwgeers H, Russell PA, Jones KD, Radonic T, Thunnissen E. Pulmonary loose tumor tissue fragments and spread through air spaces (STAS): Invasive pattern or artifact? A critical review. Lung Cancer. 2018;123(July):107-111. doi:10.1016/j.lungcan.2018.07.017 174. Pelosi G, Nesa F, Taietti D, et al. Spread of hyperplastic pulmonary neuroendocrine cells into air spaces (S.H.I.P.M.E.N.T.S): A proof for artifact. Lung Cancer. 2019;137:43-47. doi:10.1016/j. lungcan.2019.09.006 175. Metovic J, Falco EC, Vissio E, et al. Gross Specimen Handling Procedures Do Not Impact the Occurrence of Spread through Air Spaces (STAS) in Lung Cancer. Am J Surg Pathol. 2021;45(2):215-222. doi:10.1097/PAS.0000000000001642 176. Cha SI, Shin KM, Lim JK, et al. Pulmonary embolism concurrent with lung cancer and central emboli predict mortality in patients with lung cancer and pulmonary embolism. J Thorac Dis. 2018;10(1):262-272. doi:10.21037/jtd.2017.12.32 177. Price LC, Seckl MJ, Dorfm ller P, Wort SJ. Tumoral pulmonary hypertension. Eur Respir Rev. 2019;28(151):1-15. doi:10.1183/16000617.0065-2018 178. Miyano S, Izumi S, Takeda Y, et al. Pulmonary Tumor Thrombotic Microangiopathy. J Clin Oncol. 2007;25(5):597-599. doi:10.1200/JCO.2006.09.0670 179. Price LC, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy. Curr Opin Pulm Med. 2016;22(5):421-428. doi:10.1097/MCP.0000000000000297 180. Mainardi AS, Trow T. Tumor Emboli: A Rare Cause of Acute Pulmonary Hypertension. Am J Med. 2017;130(4):e137-e139. doi:10.1016/j.amjmed.2016.11.023 181. Vincenten JPL, Smit EF, Gr nberg K, et al. Is the current diagnostic algorithm reliable for selecting cases for EGFR- and KRAS-mutation analysis in lung cancer? Lung Cancer. 2015;89(1):19-26. doi:https://doi.org/10.1016/j.lungcan.2015.04.005 182. Brierley JD, Gospodarowicz M, Wittekind C. TNM Classification of Malignant Tumors. 8th ed. John Wiley & Sons, Inc.; 2017. 183. Al-Mehisen R, Al-Halees Z, Alnemri K, Al-Hemayed W, Al-Mohaissen M. Primary pulmonary artery sarcoma: A rare and overlooked differential diagnosis of pulmonary embolism. Clues to diagnosis. Int J Surg Case Rep. 2019;65:15-19. doi:10.1016/j.ijscr.2019.10.014 184. Mehta RI, Mehta RI, Choi JM, Mukherjee A, Castellani RJ. Hydrophilic polymer embolism and associated vasculopathy of the lung: prevalence in a retrospective autopsy study. Hum Pathol. 2015;46(2):191-201. doi:10.1016/j.humpath.2014.09.011 185. Miyaoka M, Hatanaka K, Uekusa T, Nakamura N. Clinicopathological features of hydrophilic polymer emboli in Japanese autopsy cases. Apmis. 2018;126(11):838-841. doi:10.1111/ apm.12891 186. Hickey TB, Honig A, Ostry AJ, et al. Iatrogenic embolization following cardiac intervention: postmortem analysis of 110 cases. Cardiovasc Pathol. 2019;40:12-18. doi:10.1016/j. carpath.2019.01.003 187. Maly V, Maly O, Kolostova K, Bobek V. Circulating tumor cells in diagnosis and treatment of lung cancer. In Vivo (Brooklyn). 2019;33(4):1027-1037. doi:10.21873/invivo.11571
RkJQdWJsaXNoZXIy MTk4NDMw